Isabel Cristina Melo Mendes

Isabel Cristina Melo Mendes

Auto-generated profile, based on publicly available information

Isabel Cristina Melo Mendes

Infectious Diseases Service and Department of Infectious Diseases, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro , Rio de Janeiro

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2024 in Annals of Medicine
Verified
Journal Article
Open access
IMIsabel Cristina Melo Mendes
Isabel Cristina Melo Mendes
AOAna Luiza Martins de Oliveira
Ana Luiza Martins de Oliveira
PTPriscila Martins Pinheiro Trindade
Priscila Martins Pinheiro Trindade
WSWallace Mendes da Silva
Wallace Mendes da Silva
CPClarisse Pimentel
Clarisse Pimentel
RGRafael Mello Galliez
Rafael Mello Galliez
Pregnant and postpartum women have a higher risk for developing severe Covid-19 and other clinical and obstetric complications. This study aims to evaluate the frequency of metabolic acidosis with elevated anion gap and describe a case series of euglycemic ketoacidosis (EKA) in pregnant and postpartum women with severe confirmed or suspected Covid-19. Observational retrospective study carried in a reference intensive care unit from May 2020 to June 2022. Cases were confirmed with positive RT-PCR or rapid antigen test. Cases with compatible clinical and radiologic findings were also included. Ketoacidosis was defined as the presence of metabolic acidosis with high anion gap (bicarbonate < 15 mEq/L and AG > 10 mEq/L) and ketonuria (2+ or more in urine test). Statistical analyses were made with R software. Of 101 admissions, 61 (60.4%) presented metabolic acidosis with high anion gap. The median age was 29 years, and most were in the third trimester. Evolution to invasive mechanical ventilation (54.0%) and obstetric complications (78.0%) were frequent. The prevalence of metabolic acidosis with high anion gap and absence of hyperlactatemia was of 43.6% (44/101). Six (5.94%) women met the criteria for EKA. Despite severity, there were no deaths. The prevalence of metabolic acidosis and EKA in pregnant and postpartum women with severe Covid-19 was high. This condition should be routinely, so it can be promptly treated.

1 January 2024 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
IMIsabel Cristina Melo Mendes
Isabel Cristina Melo Mendes
RMRoxana Flores Mamani
Roxana Flores Mamani
DCDavid Richer Araujo Coelho
David Richer Araujo Coelho
CPClarisse Pimentel
Clarisse Pimentel
Trimethoprim-sulfamethoxazole (TMP-SMX) is the primary therapeutic option for Pneumocystis jirovecii pneumonia (PCP). Gastrointestinal symptoms and cutaneous rash are common side effects, with hyperkalemia being uncommon in patients without kidney dysfunction, and myelotoxicity being even rarer. We present the case of a male patient with hypertension and a recent diagnosis of non-Hodgkin lymphoma, undergoing rituximab treatment for two months. He was admitted to the intensive care unit due to dyspnea, tachypnea, and pleuritic pain, requiring mechanical ventilation. Chest computed tomography showed bilateral and multilobed ground-glass opacities, compromising more than 80% of the lung parenchyma. Pulmonary tuberculosis and COVID-19 were ruled out. An angiotomography and Doppler ultrasound revealed an extensive pulmonary thrombus and deep venous thrombosis. Empiric treatment with TMP-SMX for PCP was initiated, but within four days, the patient experienced metabolic acidosis and severe hyperkalemia, necessitating hemodialysis. He also presented with progressive pancytopenia and critical levels of leukopenia and thrombocytopenia. The hypothesis of TMP-SMX-induced myelotoxicity was suspected. Considering the unavailability of an alternative treatment, it was opted to continue TMP-SMX and initiate a granulocyte-colony-stimulating factor. However, the patient maintained medullary deterioration, becoming refractory to the transfusion of blood derivates. On the 17th day of treatment, a clinical decision was made to suspend TMP-SMX, leading to improvements within 48 hours in marrow and kidney functions, metabolic acidosis, and hyperkalemia. Despite all efforts, the patient died after 35 days of hospitalization due to hospital-acquired infections. This case highlights the importance of clinicians recognizing potential myelotoxicity with TMP-SMX and promptly discontinuing the drug if necessary.

8 March 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
ASAmanda P O Silva
Amanda P O Silva
FLFrancine C Lóta
Francine C Lóta
MPMarilene M Paschoal
Marilene M Paschoal
ACAna H P C Carneiro
Ana H P C Carneiro
LLLuiz A A Lima
Luiz A A Lima
MDMaria Célia Djahjah
Maria Célia Djahjah
A 50-year-old HIV-positive woman, nonadherent to antiretroviral therapy, developed asthenia, weight loss, and lymphadenopathy after restarting treatment. Imaging revealed adenopathies and a breast nodule, with biopsies confirming Paracoccidioides brasiliensis. Despite initial therapy failure (trimethoprim-sulfamethoxazole), liposomal amphotericin, corticosteroids, and a regimen change led to partial improvement until a psoas abscess required drainage, ultimately stabilizing her condition.

14 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IMIsabel Cristina Melo Mendes
Isabel Cristina Melo Mendes
AOAna Luiza Martins de Oliveira
Ana Luiza Martins de Oliveira
PTPriscila Martins Pinheiro Trindade
Priscila Martins Pinheiro Trindade
WSWallace Mendes da Silva
Wallace Mendes da Silva
PFPatricia Pontes Frankel
Patricia Pontes Frankel
RGRafael Mello Galliez
Rafael Mello Galliez
Background: SARS-CoV-2 infection is associated with worse maternal and fetal outcomes. This study aims to describe the characteristics of pregnant and postpartum women with severe Covid-19 admitted to ICU. Methods and findings: It’s a retrospective cohort study evaluating pregnant and postpartum women referenced to a specialized ICU between May 2020 and June 2022. Covid-19 was confirmed with RT-PCR or rapid antigen test on a nasopharyngeal swab. Variables were described by median and IQR when numerical, and by frequency and percentage when categorical. OR with 95% CI were calculated for the evaluation of factors related to death. P-values were calculated using Pearson’s ꭓ2-test, Fisher’s exact test, Wilcoxon rank sum test, and Kruskall-Wallis test, and statistical significance was established as < 0·05. Missing data were excluded. All statistical analysis were performed using R software version 4.2.2. Of the 101 admissions, 85 (84·2%) were of pregnant women. Obesity (23·0%) and systemic arterial hypertension (13·0%) were the most prevalent medical conditions. Sixty-six (65·3%) were admitted using some type of oxygen support. Forty-seven (46·5%) evolved to mechanical ventilation. There were 61 events considered obstetric complications, with 8 stillbirths/fetal losses. The overall lethality was 15·8%. Pregnancy interruption, need for non-invasive mechanical ventilation, level of oxygen support at admission, prone maneuver, hemodialysis, and healthcare-related infections were factors associated with death. Evaluating the WHO 7-category ordinary scale, there was a trend of increase in the risk of death with higher punctuation, with a statistically significant difference of women with 5 (OR = 7·27; 95% IC = 1·17–194; p = 0·031) or 6 points (OR = 12·0; 95% IC = 1·15–391; p = 0·038) when compared to the ones with 3 points, i.e., of women admitted with a high-flow non-rebreathing mask or invasive mechanical ventilation, compared with the ones admitted at room air, respectively. The main limitations of this study are the relatively small number of participants, and the use of data derived of medical records—which are susceptible to misclassification and variable amounts of missing data. Conclusions: Pregnant and postpartum women with severe Covid-19 have high lethality and a high incidence of clinical and obstetric complications. These findings support that this population should be prioritized in public health strategies that address Covid-19.

10 February 2022 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
CTCaroline Soares Troccoli
Caroline Soares Troccoli
HBHalime Silva Barcaui
Halime Silva Barcaui
IMIsabel Cristina Melo Mendes
Isabel Cristina Melo Mendes
VGValéria Ribeiro Gomes
Valéria Ribeiro Gomes
LSLeonardo Antunes Villaca de Souza
Leonardo Antunes Villaca de Souza
CEClaudia Adelino Espanha
Claudia Adelino Espanha

27 July 2023 in Revista de Medicina
Verified
Journal Article
Open access
PDF file
RMRoxana Flores Mamani
Roxana Flores Mamani
DCDavid Richer Araujo Coelho
David Richer Araujo Coelho
IMIsabel Cristina Melo Mendes
Isabel Cristina Melo Mendes
CGClaudio Heitor Tavares Gress
Claudio Heitor Tavares Gress
AOAna Luiza Martins de Oliveira
Ana Luiza Martins de Oliveira
CPClarisse Pimentel
Clarisse Pimentel
Introdução: A Brugmansia suaveolens, conhecida como “trombeta de anjo,” é uma planta com alcaloides anticolinérgicos que provocam inibição da atividade de receptores muscarínicos no sistema nervoso central e periférico. Sua toxicidade resulta em agitação, alucinações, hipertermia, taquicardia, rabdomiolise, insuficiência renal e morte. Objetivo: Descrever um caso de intoxicação aguda por chá de trombeta, cursando com hepatite fulminante. Materiais e Métodos: Trata-se de um relato de caso, com dados clínicos e laboratoriais coletados a partir dos registros em prontuário. Termo de Consentimento Livre e Esclarecido foi obtido com familiar e o projeto foi aprovado pelo Comitê de Ética em Pesquisa. Relato de Caso: Masculino de 19 anos, saudável, internado por quadro de febre de 41°C e crises convulsivas tônico-clônicas generalizadas, evoluindo para intubação orotraqueal. Apresentava midríase fixa e rigidez de nuca. Família relata que o paciente tinha feito uso de chá de “trombeta de anjo”. À admissão, realizou tomografia computadorizada de crânio, que não evidenciou desvio de linha média, líquor sem alterações, gasometria arterial com acidose metabólica grave, insuficiência renal aguda com necessidade dialítica e insuficiência hepática aguda fulminante. Conclusões: A intoxicação pelo “chá de trombeta” é uma emergência neurológica que deve ser rapidamente reconhecida por ser potencialmente fatal. Tendo meningite como diagnóstico diferencial, é importante obter história clínica completa para investigar possível contato prévio com a planta. Para nosso conhecimento, esse é o primeiro caso a relatar quadro de hepatite fulminante pela “trombeta de anjo,” além dos sintomas neurológicos já descritos em literatura, o que corrobora ainda mais para a importância do tema em questão.